Latest news
Stay up-to-date with DIVERSA
How Can Nanotechnology Boost Gene Therapy Potential in Rare Diseases?
Rare diseases collectively affect approximately 400 million patients worldwide [1]. Nevertheless, this number is expected to increase thanks to the rapid evolution of sequencing technologies [...]
Exosome like-systems: key players for innovative targeted therapies
Exosomes, subcellular structures that act as specific carriers for transferring genetic material and information between cells, demonstrate the potential to become significant players in targeted [...]
Lipid nanoparticles: advancing your research, no matter which area you work in
Despite significant advancements in molecular medicine, obstacles such as low solubility and poor tissue accessibility impede the clinical translation of promising molecules and therapeutic agents. [...]
Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema
The potential of non-viral lipid delivery systems for improving global health has been proven once again. From rare diseases to cancer, gene editing and gene therapies [...]
Pioneering the Next-Gen Melanoma Vaccine Through Nanotech
Melanoma, a type of skin cancer originating from melanocytes, has become a global health concern due to its rising incidence. It ranks as the fifth most [...]
Nanotech-based therapies that will revolutionize the medical field in 2024
2024 is here full of new resolutions and challenges. And so, in an ever-evolving field such as medicine, it's inevitable to wonder what exciting advances the [...]
Autoimmune Diseases: One More Target for Nanotechnology
The versatility of nanotechnology to fight different diseases in diverse therapeutic areas is unprecedented. Combining nanoparticles and mRNA to treat autoimmune diseases could be the latest [...]
Revolutionizing Healthcare through the Power of Nanotechnology
Is it possible for a drug to go through a clinical trial more than once? Potent drugs with high therapeutic efficacy, such as the anticancer drug [...]
Biotechnology Landmark: the First CRISPR Medicine approved in the UK and USA
The Food and Drug Administration (FDA) has joined the UK medicines regulator and has approved the first CRISPR-Cas9 gene-editing therapy to treat sickle-cell disease [1]. UK [...]
The Revolution of our Daily Lives is at the Nanoscale
Nanotechnology, the science of manipulating matter at the nanoscale level, has made leaps and bounds in recent years, revolutionizing industries and profoundly impacting our daily lives. [...]
RNA-based Drug to reduce Cholesterol Levels
RNA-based drugs are here to revolutionize the way we know pharmacology. Covid vaccines were just the tip of the iceberg, but much more awaits in the [...]
miRNA-based Therapy delays Cancer Progression
The ability of microRNAs (miRNAs) to regulate gene expression in diverse biological processes provides new and potentially powerful candidates for therapeutic intervention. But, to date, no [...]
DIVERSA brings Innovation to Academia to foster the Development of Advanced Therapeutics
The 45th annual congress of the SEBBM (Spanish Society of Biochemistry and Molecular Biology) has recently taken place in Zaragoza. During the congress, young and experienced [...]
Organ-targeted Delivery, Simple Solutions for Complex Challenges
Applications of lipid nanoparticles (LNPs) are limited by their accumulation in the liver. The absence of a targeted delivery plan of action usually leads to the [...]
DIVERSA has been selected for the EIT Health Bridgehead Programme
DIVERSA has been selected to participate in the EIT Health Bridgehead Programme 2023, organized by the European Institute of Innovation and Technology (EIT). A new [...]
EXPLORING THE PROMISE OF GENE THERAPY AND THE ADVANTAGES OF mRNA-BASED APPROACHES
A deep dive into the world of gene therapy Gene therapy is promised to be the answer for the treatment or prevention of many genetic diseases, [...]
Peptide Applications in Biomedicine: Harnessing the power of Nanotechnology
Peptide applications in biomedicine Peptides, which are short chains of amino acids, have gained significant attention in biomedicine due to their diverse applications. Their unique properties, [...]
Let’s meet at BioSpain 2023
DIVERSA will participate in BioSpain 2023, the main biotechnology event held in Spain and one of the most important in Europe. It will take place in [...]
Embracing Virus-Free Alternatives for Gene Therapy
Gene therapies have offered unprecedented potential for treating diseases for which there was thought to be no cure. In this context, viruses have not been the [...]
Unlocking Insights into Protein Corona and Tropism!
No doubt, nanotechnology can boost the therapeutic efficiency of drug delivery. Nanodrugs, the combination of nanotechnology as the lipid nanoemulsions developed by DIVERSA, and pharmaceuticals, are [...]
The Galician Royal Academy of Sciences has awarded DIVERSA for Technology Transfer
DIVERSA has received the “Ricardo Bescansa Martínez” prestigious award for Technology Transfer from the Galician Royal Academy of Sciences (RAGC) and the Xunta de Galicia. [...]
Prospera Biotech innovates with us
Prospera Biotech has joined our will to innovate through the Activa Startups program! Prospera Biotech has been granted the Activa Startups program with DIVERSA Technologies. The [...]
New lipid-encapsulated RNA vaccine for pancreatic cancer treatment
A new article by Rojas et al. has recently been published in Nature, describing the use of a new RNA vaccine to fight against pancreatic cancer, [...]
Diagnosis and treatment for osteoarthritis, all in one
A new paper is out! DIVERSA has participated in the development of innovative treatment for osteoarthritis in a project led by research groups from the Centre for [...]
Do you want to innovate with us?
"Activa Startups" is an initiative of the Ministry of Industry, Trade, and Tourism that supports collaboration between emerging small and medium enterprises (SME) and startups with [...]
One step closer to full digitalization at DIVERSA
Digitalization is a critical aspect of modern business, allowing companies to automate processes, enhance customer experience, and collect and analyze data to make data-driven decisions. Grants [...]
The real scientific impact comes from translation
Creating an impact in the real world requires innovation. Through translation, ideas reach their full potential and result in benefits for society. At DIVERSA we know [...]
Rewarding DIVERSA’s young talent at SLPC-CRS
Great news for the DIVERSA team, and specially for one of its members! Laura Taina-González's hard work and talent have been recognized at the 4th Spanish Portuguese [...]
The impact of women in science
Today, inspired by the "Choose to Challenge" International Women’s Day theme, we share with you how women are transforming science, specifically in oncology. And we do [...]
A unique technology, adapted to diverse type of molecules
The therapeutic revolution is global in nature. For this reason, to bring DIVERSA reagents to dozens of laboratories, we have restructured our product catalog and established [...]
Committed to strengthen trade ties in India
The Asian country is growing the pharmaceutical industry at an unprecedented rate and DIVERSA wants to join the challenge! India stands as a promising power in [...]
DIVERSA has been officially qualified as IEBT
This IEBT recognition, conferred by the Xunta de Galicia, highlights DIVERSA's innovative character and will help hire new talent. What does IEBT mean? An [...]
DIVERSA gets into the top 100 innovative startups 2022
El Referente, which owns the most prominent Spanish database of startups and investors in real-time, publishes the third edition of the most innovative Spanish startups ranking. [...]
Highly qualified professionals recognized through a Senior Talent Program
Recently, Víctor A. Francis and Abi J. Vázquez were recognized as “Talento Senior” and awarded a three-year grant by the Galician Innovation Agency (GAIN), which confirms [...]
Finalists at Spin-off PuntoGal Awards organized by PuntoGal and GCiencia
DIVERSA ranked finalist during the 6th edition of Spin-off PuntoGal Awards that took place at the auditorium of the Faculty of Economic and Business Science of [...]
Quality grant for a quality PhD student
Succeeding in getting a PhD grant is not an easy task. It requires time and energy to apply for it. But, beyond that, it requires talent. [...]
Catalysing DIVERSA under the EIT Health’s Bridgehead program
DIVERSA got selected by EIT Health’s Bridgehead program to access new markets, and we could not be happier. Keep reading to see what is coming! [...]
An innovation plan for 2022 and 2023
The Galician Innovation Agency has awarded DIVERSA through the InnovaPeme program to implement its innovation plan in 2022 and 2023. DIVERSA is driven by innovation [...]
Dr. Gabriela Garrastazu: a new member at DIVERSA
We are very happy to announce that we already have Gabriela Garrastazu with us as a Project Leader. The DIVERSA team keeps growing! Gabriela's professional path [...]
DIVERSA is awarded an InnovaPeme grant for Innovation Excellence
PARTICIPAMOS EN EL PROGRAMA INNOVAPEME con nuestro PLAN DE INNOVACIÓN DIVERSA TECHNOLOGIES 2022-2023 DIVERSA Technologies, S.L. ha puesto en marcha su Plan de Innovación de cara [...]
A biotech spin-off company among the winners of the PEL awards
DIVERSA has been awarded the prestigious award by the “Deputación da Coruña” among several emerging companies. The rationale of PEL awards The PEL awards [...]
DIVERSA achieves the ‘Galician Excellence’
Our CEO and co-founder Maria de la Fuente received the Title of Galician Excellence from the Association of Galician Entrepreneurs in Catalonia. Already contributing to [...]
DIVERSA plans to grow internationally with the support of the ICEX NEXT program
DIVERSA has been selected under the ICEX NEXT program on a competitive basis amongst more than 150 Spanish SMEs, and here we tell you how this [...]
Small molecules: towards clinical development
The potential of nanomedicine to provide therapeutic benefits over conventional drug formulations has been proven with other drugs in the market. One example of success is [...]
Identifying new delivery systems for nucleic acid therapeutics
We are happy to share that Laura Taina González, our PhD student, had the opportunity to join Vaccine Design and Delivery (VDD). VDD is a group [...]
Improving the fate of protein therapeutics
The potential of proteins for the treatment of diseases Protein therapeutics represent a powerful field for the treatment of many diseases, having shown its potential for several [...]
BioEurope Spring 2022, March 28-31
DIVERSA will be present at BioEurope Spring 2022. Next March 28th-31st will take place the BioEurope Spring, one of the most important events of the year in [...]
DIVERSA is participating in the Bio Galicia Summit
DIVERSA is participating in the Bio Galicia Summit (March 2-4), an online event of biotechnology applied to the health and agri-food fields, organized by BioIncubaTech, a [...]
DIVERSA will commercialize its ready-to-go kits through tebu-bio
In February 2022, a month after DIVERSA’s incorporation, commercial activities for the company will start at large with the launch into market of our ready-to-go [...]
DIVERSA to attend SLAS2022 International Conference and Exhibition
February is the coldest month of the year in Boston, the world’s largest Healthtech and biotech hub. Flying from the mild Mediterranean winter temperatures to the [...]
DIVERSA Technologies goes to market with its innovative delivery solutions
The spin-off co-founded by María de la Fuente, Abi Judit Vázquez and Rafael López, participated by the Health Research Institute of Santiago de Compostela (IDIS) [...]
